Back to company

BIODANE PHARMA A/S: Financial statements 2017

CVR: 28310102

BIODANE PHARMA A/S (CVR 28310102) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 967,640 and a net result of DKK 102,788 compared with DKK 32,975 the year before. That is an increase of 29.5% compared with the year before. Equity amounted to DKK 1,869,305. The solvency ratio was 90.5%. The company had 1 employee in the financial year.

Gross Profit
967,640 kr.
Profit/Loss
102,788 kr.
Equity
1,869,305 kr.
Total Assets
2,065,279 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-968 t.103 t.1.9 mio.1
2016-747 t.33 t.767 t.1
2015-438 t.-253 t.734 t.-
2014-279 t.-250 t.987 t.-
2013-106 t.-977 t.-263 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like BIODANE PHARMA A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

BIODANE PHARMA A/S: The 2016 annual report is outMay 26, 2017

BIODANE PHARMA A/S has published its annual report for 2016. Gross profit came to DKK 747,313, and the net result was DKK 32,975.

About BIODANE PHARMA A/S

BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Gunner Kreutzer Jakobsen. The company is owned by BIODAN A/S. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity amounted to DKK 2,505,002.